Skip to Content

Cefotaxime Sodium Injection

Last Updated: March 16, 2020
Status: Current

Products Affected - Description
    • Claforan injection, Baxter, 1 gram/50 mL, frozen premixed bag, 24 count, NDC 00039-0038-05 - discontinued
    • Claforan injection, Baxter, 2 gram/50 mL, frozen premixed bag, 24 count, NDC 00039-0039-05 - discontinued
    • Cefotaxime Sodium powder for solution for injection, Hikma, 1 gram, vial, 25 count, NDC 00143-9931-25
    • Cefotaxime Sodium powder for solution for injection, Hikma, 10 gram, vial, 1 count, NDC 00143-9935-01
    • Cefotaxime Sodium powder for solution for injection, Hikma, 2 gram, vial, 25 count, NDC 00143-9933-25
    • Cefotaxime Sodium powder for solution for injection, Hikma, 500 mg, vial, 10 count, NDC 00143-9930-10
Reason for the Shortage
    • Hospira has discontinued Claforan. Sanofi-Aventis manufactured Claforan for Hospira and is no longer making the product.
    • Baxter discontinued Claforan in late-2015.
    • Hikma is not currently marketing cefotaxime injection.

Estimated Resupply Dates

    • Apollo Pharmaceuticals is temporarily importing cefotaxime 1 gram and 2 gram vials.

Alternative Agents & Management

    • FDA is allowing temporary importation of cefotaxime 1 gram and 2 gram vials from Apollo Pharmaceuticals and its distributor FFF Enterprises. The cefotaxime is supplied by SteriMax from Canada. Customers can call FFF Enterprises at 1-800-843-7477 to place orders. More information can be found at https://www.fda.gov/media/130296/download.

Updated

Updated March 16, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 31, 2013 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide